Work

Opicapone for the Treatment of Parkinson’s Disease "Off" Episodes: Pharmacology and Clinical Considerations

Year: 2021

Type: article

Source: Clinical Drug Investigation

DOI: 10.1007/s40261-021-01109-3

Authors: Amnon A. Berger, Christopher Robinson, Ariel Winnick, Jonathan Izygon, Binil M. Jacob, Mackenzie J. Noonan, Alan D. Kaye, Jessica S. Kaye, Adam M. Kaye, Elyse M. Cornett, Rutvij J. Shah, Omar Viswanath, Ivan Urits

Institutions: Beth Israel Deaconess Medical Center, Harvard University, Ben-Gurion University of the Negev, Soroka Medical Center, University of California, Berkeley, Louisiana State University in Shreveport, Louisiana State University Health Sciences Center Shreveport, University of the Pacific, Creighton University, CHI Health Creighton University Medical Center - Bergan Mercy, University of Arizona College of Medicine- Phoenix, SouthCoast Health

Language: English

Topic: Parkinson's Disease Mechanisms and Treatments

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4200514396

FWCI: 0.24

Cites: 54

Cited by: 3

Related to: 10